May 29, 2017 / 9:00 AM / 3 months ago

BRIEF-Takara Bio starts first test of Phase II clinical trial of HF10

May 29(Reuters) - Takara Bio Inc

* Says it started first test of Phase II clinical trial of HF10, which will be used for treatment in patients with unresectable or metastatic melanoma, on May 26

Source text in Japanese: goo.gl/cxBrk8

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below